alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
FINANCIAL STATEMENTS OF EDUCATIONAL MEDICAL FOR THE SIX MONTHS ENDED 
SEPTEMBER 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                       7,285,945
<SECURITIES>                                         0
<RECEIVABLES>                                9,233,666
<ALLOWANCES>                                 1,174,210
<INVENTORY>                                          0
<CURRENT-ASSETS>                            18,162,371
<PP&E>                                      14,169,844
<DEPRECIATION>                               6,120,493
<TOTAL-ASSETS>                              38,328,075
<CURRENT-LIABILITIES>                        6,546,850
<BONDS>                                      2,824,316
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        73,972
<OTHER-SE>                                  28,989,633
<TOTAL-LIABILITY-AND-EQUITY>                38,328,075
<SALES>                                     26,648,687
<TOTAL-REVENUES>                            26,648,687
<CGS>                                       24,300,397
<TOTAL-COSTS>                               24,300,397
<OTHER-EXPENSES>                               625,488
<LOSS-PROVISION>                               561,715
<INTEREST-EXPENSE>                            (167,266)
<INCOME-PRETAX>                              1,328,313
<INCOME-TAX>                                   531,440
<INCOME-CONTINUING>                            796,873
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   796,873
<EPS-PRIMARY>                                     0.11
<EPS-DILUTED>                                        0
        

</TABLE>
#### The People of the State of New York, Respondent, v Francis Pezzimenti, Appellant.

(Appeal No. 2.)

[665 NYS2d 499]

—Judgment unanimously modified on the law and as modified affirmed. Same Memorandum as in *People v Pezzimenti,*245 AD2d 1030 [decided herewith]). (Appeal from Judgment of Cattaraugus County Court, DiTullio, J.—Petit Larceny.) Present— Pine, J. P., Lawton, Wisner, Balio and Fallon, JJ.
Opinion filed May 15, 2014



### In The 

# Eleventh Court of Appeals

_____ _

_____



### No. 11

- 1 4

- 00 1 11

- C V

______ _ ____



### IN THE INTEREST OF W.L.D. AND D.T.D., CHILDREN

On Appeal from the 91s t District Court

Eastland County, Texas

Trial Court Cause No. CV

- 11

- 42,439

M E M O R A N D U M O P I N I O N

Kelli Sue Bouget, Appellant, has filed a notice of appeal from an order

holding her in contempt for failing to comply with a previous order of the trial

court regarding the possession of her children. Upon filing the appeal

, t he clerk of

this court notified Appellant by letter that it did not appear this court had

jurisdiction to entertain her direct appeal from an o rder of contempt . We requested

that Appellant respond by May 5, 2014, and show grounds to continue the appeal.

Appellant has not filed a response addressing the jurisdictional issue. We dismiss

th e appeal.2 A judgment of contempt is not appealable on direct appeal

. Tex. Animal

Health Comm’n v. Nu nley , 647 S.W.2d 951, 952 (Tex. 1983); In re Smith , 310

S.W.3d 9 08, 913 (Tex. App.

— Eastland 2010 , orig. proceeding) ; Tracy v. Tracy

,
219 S.W.3d 527, 530 (Tex. App.

— Dallas 2007, no pet.) . The only available

means of review from an order of contempt are wri t s of mandamus and writ s of

habeas corpus

. In re Long , 984 S.W.2d 623, 625 (Tex. 1999) (orig. proceeding).

Because this is a direct appeal from a contempt order , we have no jurisdiction.

Accordingly, we must dismiss this appeal.

The appeal is dismissed for want of jurisdiction.

PER CURIAM

May 15, 2014

Panel consists of: Wright, C.J.,
Willson, J., and Bailey, J.
<PAGE>
                                                                         A469759
                                                                           FILED
                                                                     DEC 22 1995


                           CERTIFICATE OF AMENDMENT OF
                          ARTICLES OF INCORPORATION OF
                                      VOXEL

Allan M. Wolfe, MD and Stephen Hart certify that:


1.    They are the president and secretary, respectively, of VOXEL, a California
      corporation.

2.    Article III of the Articles of Incorporation of this corporation is
      amended to read in its entirety as follows:

      The total authorized capital stock of this corporation consists of
      25,000,000 shares, consisting of 15,000,000 shares of common stock
      ("Common Stock") and 10,000,000 shares of preferred stock. The preferred
      shares may be issued from time to time in one or more series. The Board of
      Directors is authorized to fix the number of shares of any series of
      preferred shares and to determine the designation of any such series. The
      Board of Directors is also authorized to determine or alter the rights,
      preferences, privileges, and restrictions granted to or imposed upon any
      wholly unissued series of preferred shares and, within the limits and
      restrictions stated In any resolution or resolutions of the Board of
      Directors originally fixing the number of shares constituting any series,
      to increase or decrease (but not below the number of shares of such series
      then outstanding) the number of shares of any such series subsequent to
      the issue of shares of that series.'

3.    The foregoing amendment of the articles of incorporation has been duly
      approved by the board of directors and by the required vote of
      shareholders in accordance with Section 902 of the Corporations Code. The
      total number of outstanding shares of common stock of the corporation Is
      4,228,869. No other class of capital stock is outstanding. The number of
      shares voting in favor of the amendment equaled or exceeded the vote
      required. The percentage vote required was more than 50%.

We further declare under penalty of perjury under the laws of the State of
California that the matters set forth in this certificate are true and correct
of our own knowledge.

Date: December 20, 1995



                                             /s/ Allan M. Wolfe, M.D.
                                             -----------------------------------
                                             Allan M. Wolfe, M.D., President


                                             /s/ Stephen Hart
                                             -----------------------------------
                                             Stephen Hart, Secretary
#### UNITED STATES of America, Appellee, v. Rigoberto CHAVEZ-CUEVAS, Appellant.

No. 11-1495.

United States Court of Appeals, Eighth Circuit.

Submitted: July 14, 2011.

Filed: July 26, 2011.

Before MELLOY, BOWMAN, and SHEPHERD, Circuit Judges.

PER CURIAM.

Rigoberto Chavez-Cuevas appeals the sentence the district court1 imposed after he pled guilty to conspiring to distribute more than 50 grams of a mixture or substance containing methamphetamine, in violation of 21 U.S.C. §§ 841(a)(1), b(1)(B)(viii), and 846. Counsel has moved to withdraw, and has filed a brief under *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967).

We conclude that the district court did commit any significant procedural error in sentencing Chavez-Cuevas, and imposed a substantively reasonable sentence. *See Gall v. United States,*552 U.S. 38, 51, 128 S.Ct. 586, 169 L.Ed.2d 445 (2007) (in reviewing sentence, appellate court first ensures that district court committed no significant procedural error, and then considers substantive reasonableness of the sentence under abuse-of-discretion standard; if sentence is within Guidelines range, appellate court may apply presumption of reasonableness); *United States v. Berni,*439 F.3d 990, 992-93 (8th Cir.2006) (per curiam) (reviewing sentence involving U.S.S.G. § 5K1.1 downward departure for reasonableness using abuse-of-discretion standard; sentence was reasonable where court correctly calculated Guidelines range, permissibly applied § 5K1.1 departure, and considered resulting adjusted range and 18 U.S.C. § 3553(a) factors); *United States v. Haack,*403 F.3d 997, 1004 (8th Cir.2005) (describing ways in which court might abuse its discretion at sentencing).

Having reviewed the record independently under *Penson v. Ohio,*488 U.S. 75, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), we have found no nonfrivolous issues. Accordingly, we grant counsel’s motion to withdraw, and we affirm.

1

. The Honorable Jimm Larry Hendren, Chief Judge, United States District Court for the Western District of Arkansas.
<PAGE>
                                                                         A448202
                                                                           FILED
                                                                    JUNE 24 1994


                            CERTIFICATE OF AMENDMENT
                                       OF
                            ARTICLES OF INCORPORATION
                                       OF
                                      VOXEL


Allan M. Wolfe, M.D., and Stephen Hart certify that:

1.    They are the president and the secretary, respectively, of Voxel, a
      California corporation.

2.    Article III of the articles of incorporation of this corporation is
      amended to read as follows:

      "The total authorized capital stock of this corporation consists of
      25,000,000 shares, consisting of 15,000,000 shares of common stock
      ("Common Stock"), and 10,000,000 shares of preferred stock. The initial
      series of preferred stock shall be designated "Series A Preferred Stock"
      and "Series B Preferred Stock." The Series A Preferred Stock shall consist
      of 492,904 shares and the Series B Preferred Stock shall consist of
      6,407,291 shares. On the amendment of this article, each outstanding
      5.145346 shares of Common Stock are combined and converted into one
      share."

3.    The foregoing amendment of articles of incorporation has been duly
      approved by the board of directors.

4.    The foregoing amendment of articles of incorporation has been duly
      approved by the required vote of shareholders in accordance with Section
      902 of the Corporations Code. The total number of outstanding shares of
      common stock of the corporation is 1,475,000; the total number of
      outstanding shares of Series A Preferred stock of the corporation is
      492,904; the total number of outstanding shares of Series B Preferred
      stock of the corporation is 6,322,291. The number of shares voting in
      favor of the amendment in each class and all classes voting as a whole
      each equaled or exceeded the vote required. The percentage vote required
      was more than 50%.

We further declare under penalty of perjury under the laws of the State of
California that the matters set forth in this certificate are true and correct
of our own knowledge.

Date:  June 21, 1994


                                             /s/ Allan M. Wolfe, M.D.
                                             -----------------------------------
                                             Allan M. Wolfe, M.D., President


                                             /s/ Stephen Hart
                                             -----------------------------------
                                             Stephen Hart, Secretary
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Matthew B. Smith, state and attest that:



|1. | I am the President of Main Place Funding, LLC (the Registrant).
|-- | -----------------------------------------------------------------



|2. | I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|-- | ---------------------------------------------------------------------------------------------------------------------------------

the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2007 (the Report) containing financial statements fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Registrant for the periods presented.



|                    
|--------------------
|/s/ Matthew B. Smith
|Matthew B. Smith    
|President           
|March 31, 2008
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2966 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 2966

 To amend the Internal Revenue Code of 1986 to deny any deduction for 
        direct-to-consumer advertisements of prescription drugs.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 19, 2009

    Mr. Nadler of New York introduced the following bill; which was 
              referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to deny any deduction for 
        direct-to-consumer advertisements of prescription drugs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Say No to Drug Ads Act''.

SEC. 2. DISALLOWANCE OF DEDUCTION FOR DIRECT-TO-CONSUMER ADVERTISEMENT 
              OF PRESCRIPTION DRUGS.

    (a) General Rule.--Part IX of subchapter B of chapter 1 of the 
Internal Revenue Code of 1986 (relating to items not deductible) is 
amended by adding at the end the following new section:

``SEC. 280I. DIRECT-TO-CONSUMER ADVERTISEMENT OF PRESCRIPTION DRUGS.

    ``No deduction shall be allowed under this chapter for any amount 
paid or incurred for a direct-to-consumer advertisement of a 
prescription drug.''
    (b) Clerical Amendment.--The table of sections for part IX of 
subchapter B of chapter 1 of such Code is amended by adding at the end 
thereof the following new item:

``Sec. 280I. Direct-to-consumer advertisement of prescription drugs.''.
    (c) Effective Date.--The amendments made by this section shall 
apply to amounts paid or incurred after December 31, 2009.
                                 <all>
```
Exhibit 21

Subsidiaries of AmeriVest Properties Inc.

Subsidiary Name

State of IncorporationAmeriVest Broadway Properties Inc.

ColoradoAmeriVest Sheridan Center Inc.

ColoradoAmeriVest Properties Texas Inc.

TexasAmeriVest Properties Indiana Inc.

IndianaAmeriVest Inverness Inc.

ColoradoAmeriVest Arrowhead Inc.

ArizonaAmeriVest Kellogg Inc.

ColoradoKellogg Executive Suites Inc.

ColoradoAmeriVest Parkway Inc.

TexasAmeriVest Centerra Inc.

ColoradoAmeriVest Chateau Inc.

ColoradoAmeriVest Black Canyon Inc.

ArizonaAmeriVest Keystone Inc.

IndianaAmeriVest Mesa Inc.

ArizonaAmeriVest Scottsdale Inc.

ArizonaAmeriVest Greenhill Inc.

TexasAmeriVest Camelback Inc.

ArizonaAmeriVest Hackberry View

TexasAmeriVest Properties Texas

TexasAmeriVest Oak Lawn Inc.

Texas




QuickLinks
#### In the Matter of the Estate of Michael J. Proto, Deceased. Marilyn Proto et al., Respondents; Phyllis Lanza, Appellant.

[666 NYS2d 37]

—In a proceeding pursuant to SCPA § 2103 to discover property withheld from the decedent’s estate, Phyllis Lanza appeals from an order of the Surrogate’s Court, Kings County (Scholnick, S.), dated December 4, 1996, which, *inter alia,*directed that the decedent’s one-half interest in certain real property be returned by her to the decedent’s estate.

Ordered that the order is affirmed, with one bill of costs payable by the appellant.

Contrary to the appellant’s contention, the petitioner was not prohibited by the doctrine of “unclean hands” from seeking to have the decedent’s one-half interest in the property at issue reconveyed by the appellant to the decedent’s estate *(cf., Pattison v Pattison,*301 NY 65; *Lagonegro v Lagonegro,*187 AD2d 490; *Langdon v Langdon,*138 AD2d 358).

*521The appellant’s remaining contentions are without merit. Bracken, J. P., Thompson, Goldstein and Lerner, JJ., concur.
#### The People of the State of New York, Respondent, v Deborah Saffold, Appellant.

[667 NYS2d 521]

—Judgment unanimously affirmed. Memorandum: We reject the contention of defendant that she was denied meaningful representation because defense counsel jointly represented defendant and co-defendant, her husband. The record establishes that, after defendant and codefendant were arrested, they retained the same counsel to represent them. After defendant and codefendant were indicted and arraigned, defendant informed counsel that she wished to cooperate and to enter into a plea agreement. Based upon the conflict of interest arising therefrom, counsel sought permission from County Court to be relieved of his representation of defendant. The court granted counsel’s request and assigned defendant new counsel. New counsel moved to disqualify defendant’s former counsel from representing codefendant or, in the alternative, for a severance. The court granted counsel’s request for a severance. Defendant subsequently pleaded guilty pursuant to a plea agreement.

Joint representation of defendants by a single attorney creates a potential conflict of interest that may deprive each defendant of meaningful representation *(see, People v Recupero,*73 NY2d 877, 878). “Joint representation is not per se forbidden, however, and vacatur of the plea will only result where the defendant demonstrates that a significant possibility of a conflict of interest existed bearing a substantial relationship to the conduct of the defense” *(People v Recupero, supra,*at 879). *1074Defendant failed to demonstrate that the joint representation created a conflict of interest that substantially affected the conduct of the defense *(see, People v Recupero, supra; People v McDonald,*68 NY2d 1, 9, *rearg dismissed*69 NY2d 724).

We further conclude that defendant’s sentence is neither unduly harsh nor severe. (Appeal from Judgment of Onondaga County Court, Cunningham, J.—Criminal Possession Controlled Substance, 2nd Degree.) Present—Denman, P. J., Law-ton, Wisner, Balio and Boehm, JJ.
<PAGE>

                                  EXHIBIT 11
                                  ----------

             STATEMENT REGARDING COMPUTATION OF EARNINGS PER SHARE


                                                 Years Ended March 31,
                                           ------------------------------------
                                              2000         1999         1998
                                              ----         ----         ----

Weighted average number
  of common shares outstanding used
  in basic EPS calculation                  203,981      209,786      212,602

Add common stock equivalents
  for shares issuable under
  Stock Option Plans                          2,720        3,566        1,026
                                           --------      -------      -------

Weighted average number of shares
  outstanding adjusted for common
  stock equivalents                         206,701      213,352      213,628
                                           ========      =======      =======

Net income                                 $ 62,036      157,364      142,177
Basic earnings per share                   $    .30          .75          .67
Diluted earnings per share                 $    .30          .74          .67
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Name of Committee:*                     Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PAR15-352, Occupational Safety and Health Training Projects.                

*Date:*                     December 6-7, 2017.                

*Time:*                     1:00 p.m.-6:00 p.m., EST.                

*Place:*                     Teleconference.                

*Agenda:*                     The meeting will include the initial review, discussion, and evaluation of applications received in response to PAR15-352, Occupational Safety and Health Training Projects.                

*For Further Information Contact:*                     Michael Goldcamp, Ph.D., Scientific Review Officer/CDC, 1095 Willowdale Road, Mailstop H1808, Morgantown, West Virginia 26505,(304) 285-5951;                     *mgoldcamp@cdc.gov.*

                    The Director, Management Analysis and Services Office, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Claudette Grant,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. 2017-21818 Filed 10-10-17; 8:45 am]

 BILLING CODE 4163-18-P